Search

Ammar Abdulrahman Jairoun,1,2 Sabaa Saleh Al-Hemyari,2,3 Moyad Shahwan,4,5 Faris El-Dahiyat,6 Maimona Jairoun,4 Saleh Karamah AL-Tamimi,7 Ramzi A Mothana,8 Ahmed Husham Khattab4 1Health and Safety Department, Dubai Municipality, Dubai, United Arab Emirates; 2Discipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, 11500, Malaysia; 3Department of Pharmacy, Ministry of Health and Prevention, Dubai, United Arab Emirates; 4Department of Clinical Sciences, College of Pharmacy and Health Sciences, Ajman University, Ajman, 346, United Arab Emirates; 5Center of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, Ajman, 346, United Arab Emirates; 6College of Pharmacy, Al Ain University, Al Ain, United Arab Emirates; 7Faculty of Pharmacy, Aden University, Aden, Yemen; 8Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Saudi ArabiaCorrespondence: Ammar Abdulrahman JairounHealth and Safety Department, Dubai Municipality, Dubai, 67, United Arab EmiratesTel +971558099957Email Dr_ammar_91_@hotmail.comBackground: The flux of pharmaceutical data can have a negative impact on the complexity of a pharmacist’s decision-making process, which will demand an extensive evaluation from healthcare providers trying to choose the most suitable therapeutic plans for their patients.Objective: The current study aimed to assess the beliefs and implementations of community pharmacists in the UAE regarding evidence-based practice (EBP) and to explore the significant factors governing their EBP.Setting: Community pharmacies in Dubai and the Northern Emirates, UAE.Methods: A descriptive cross-sectional study was conducted over six months between December 2017 and June 2018. Community pharmacists who had three months’ professional experience or more and were registered with one of three regulatory bodies (Ministry of Health, Health Authority Abu Dhabi, or Dubai Health Authority) were interviewed by three trained final-year pharmacy students. Face-to-face interviews were then carried out and a structured questionnaire was used.Metrics: The average beliefs score was 36% (95% CI: [34%, 39%]) compared to an implementation score of 35% (95% CI: [33%, 37%]).Results: A total of 505 subjects participated in the study and completed the entire questionnaire. On average, participants scored higher in beliefs score than implementation score. The results of the statistical modelling showed that younger, female, higher-position pharmacists with more experience and with low percentages of full-time working, and graduates from international/regional universities were more likely to believe in and implement the concept of EBP.Conclusion: A gap was identified between the beliefs and implementation of EBP. Developing educational EBP courses in undergraduate pharmacy curricula is of high importance, not only to increase knowledge levels but also to encourage commitment in those pharmacists to strive for professionalism and to support the provided patient care with evidence.Keywords: evidence-based practice, beliefs, practice, community pharmacist

Aims To assess the association between abnormal hepatic enzyme, lipid levels and glycemic control in patients with type 2 Diabetes Mellitus. As Liver biomarkers serve as an effective indicator of liver injury in patients whom liver functions are somewhat above average. The abnormality of these markers acts as an alarming sign to the liver function. Since type 2 diabetes can negatively affect the liver via insulin resistance, these biomarkers maybe linked with the severity of the disease. Materials and methods A cross-sectional study was carried out at private health care center. A total of 453 diabetic patients. Socio-demographic, clinical, and laboratory data were obtained from the medical records of patients. Statistical analysis was carried out using the Statistical Package for the Social Sciences (SPSS, version 23). Results A total number of 453 patients with T2DM were included in this study. Of the 453 patients, 366 (80.8%) had only one abnormal hepatic profile parameter (ALT, AST & Albumin), 29 (6.4%) had two abnormal hepatic parameters and 11 (2.4%) had more than two abnormal hepatic profile parameters. The results of statistical modeling showed that mean Albumin, mean ALT, and mean AST are jointly highly associated with poorly controlled diabetes mellitus (HbA1c ≥ 7). Lipid profiles (TC, LDL-C and TG) were significantly associated with abnormal hepatic findings. Conclusion Current study revealed significant association in liver biomarkers among type 2 diabetic patients.